Human Health and Potential (HHP)

A molecule found in Aedes mosquito saliva modulates the host body’s immune response during chikungunya infection, highlighting that mosquitoes may be more than just viral carriers.

A novel RNA-based molecular tool offers an innovative way to detect, amplify and respond to genetic signals within cells with unprecedented modularity.

A novel broad-spectrum drug candidate stalls replication of several SARS-CoV-2 variants and other coronaviruses, with the potential to boost preparedness against future pandemics.

Soft textures, fibrous structures and improved protein digestibility—plant-based meat products could have these all, when processed using the right concentration and type of enzyme.

Researchers identify a molecular driver of cell death in a rare neurodegenerative disease and show how targeted oligonucleotide therapies can combat the process.

A*STAR researchers uncover how bacterial hideouts created during tuberculosis infections can also protect and feed other opportunistic invaders.

A*STAR researchers have developed a microneedle patch technology that can deliver drugs and vaccines more effectively and with minimal invasiveness.

A new cellular model of colorectal cancer helps identify high-risk subtypes likely to resist standard treatments and proliferate in response.

By examining how soy protein concentrates affect protein fibrous texture, scientists address existing quality control issues faced by meat-alternative manufacturers.

Nanopore sequencing and a self-enhancing AI model team up to enable a faster and more accurate method for reading synthetic genes.

A*STAR researchers develop a smarter delivery system for mRNA vaccines that boosts their targeting abilities and biological safety.

A tri-enzyme delivery platform restores biochemical balance and promotes healing in skin wounds.